Seungwon Lim is listed as a director on 1 SEC Form D filing by 1 issuer in Aug 2025: D&D Pharmatech Inc. (Seongnam-Si, Korea, Republic of (as filed: M5) — pharmaceuticals — 2025; $10.8M reported sold to 8 investors).
What this means One deal on file with the SEC, filed Aug 2025. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Daehyun Shin (1 shared filing), Seol-Heui Han (1 shared filing), Seulki Lee (1 shared filing), Sunghoon Hong (1 shared filing) and Sungmook Lim (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Seungwon. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Seungwon Lim and found 1 difference: Form D filed 42 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.